Mark Kuehn's Contact Details

Mark Kuehn's Company Details

GeneTesting

Tampa, FL, US • 100 - 249 Employees
Healthcare Facility/Healthcare Services

Our Lab CGX panels test for an industry leading 134-gene markers, which allow the provider and patient to understand if they are predisposed to acquiring cancer. PGX testing can show how a patient's body is likely to metabolize many common medications. This allows healthcare providers to act on the results to prescribe medications with less risk of side effects, including overdosing or ineffectiveness. Not all people respond to the standard dose. Genetic testing helps the provider to select the right drug and best dose for each patient. Some prescriptions may have an adverse effect on a patient that has a genetic marker. We also offer DME (Durable Medical Equipment) for patients who are experiencing pain in given areas.The advantages of genetic screening to help prevent potential hereditary cancers and customize pharmacological therapies are immeasurable. Providing CGX and PGX testing to the community places the power of positive health outcomes within the hands of the patient. With the information provided by CGX and PGX testing, patients and GeneTesting can work together to reduce the risk of developing hereditary cancers and make a positive impact on the improving pharmacological efficacy.